Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital

• Published in: Hemoglobin 2021-09, Vol.45 (5), p.303-308
• Main Authors: Delicou, Sophia, Aggeli, Konstantina, Magganas, Konstantinos, Patsourakos, Dimitrios, Xydaki, Aikaterini, Koskinas, John
• Format: Article
• Language: English
• Subjects: Acute chest syndrome (ACS); Acute Chest Syndrome - diagnosis; Acute Chest Syndrome - etiology; Acute Chest Syndrome - therapy; Acute Disease; Adult; Anemia, Sickle Cell - complications; Anemia, Sickle Cell - therapy; Hospitals; Humans; outcome; Pulmonary Embolism; sickle cell disease; Thalassemia - complications
• ISSN: 0363-0269; 1532-432X
• DOI: 10.1080/03630269.2021.2006690

Acute chest syndrome (ACS) is a common cause of death for sickle cell disease patients. This syndrome is defined as: respiratory symptoms, new X-ray findings developed and/or fever; ACS requires prompt treatment to avoid clinical deterioration and death in adults with sickle cell disease. Sixteen episodes of acute chest syndrome were studied in 16 adults with sickle cell disease. The clinical and radiological findings, treatment, response and outcome of the episode were evaluated respectively. The patient's past history and comorbidities were taken into account in the outcome and days of hospitalization. Fourteen patients recovered with no sequelae; one patient who required mechanical ventilation also recovered; one patient died due to pulmonary emboli. The mean hospitalization days were 7.43.